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venous system. After a mean follow-up of 25 months, AVNRT did
not recur in any patient.
Conclusions: Catheter ablations were efficiently and effectively
performed floroless in adults with AVNRT using 3D Electro-
anatomical mapping using St. Jude En-site system using NavX
patches. This non fluoroscopic technique was feasible, posed no
additional safety concerns, and long term success is documented
on follow up.
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Background: Supraventricular tachycardias cause disabling
symptoms and affect quality of life. Management is pharmaco-
logical and catheter based. Pharmacological treatment is limited
by side effects and less efficacious. Radiofrequency catheter
ablation offers cure for Atrioventricular nodal re-entranrant
tachycardia (AVNRT) with minimal adverse events. Catheter
ablation can be defined as the use of an electrode catheter to
destroy small areas of myocardial tissue or conduction system, or
both, that are critical to the initiation or maintenance of cardiac
arrhythmias. Radio-frequency current is alternating current that
is delivered at cycle lengths of 300 to 750 kHz when used for
catheter ablation. Tissue temperature 50 oC or more causes irre-
versible injury, power- 40- 50 Watts.
Methods: Patients presenting to our centre between 2010-14
diagnosed as AVNRT on EPS were included in this study. Patients
further underwent radiofrequency ablation.
Results: Total number of patients-95.Mean age-38±14yrs.Male/
Female-53/42 .In slow efast pathway type out of 87 patients 80
patients (91%) had successful ablation. In atypical fast-slow path
type out of 5patents 4patiens (80%) had successful ablation. In
sow-intermediate type out of 3 patients 3 (100%) had successful
ablation.
Conclusions: Radiofrequency catheter ablation is safe and effec-
tive treatment for AVNRT. High success rates with low compli-
cation/relapse seen at our center.
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Background: Radiofrequency ablation has emerged as a curative
treatment choice for symptomatic patients with Atrioventricular
Accessory pathways. The aim of the study was to study the effi-
cacy of radiofrequency ablation of symptomatic patients with
accessory pathways and to compare the rates of successful abla-
tion in pathways based on location.
Methods: During the period from july2010 to june2014, 154 pa-
tients with various manifestations of AP underwent EPS and RFA
in NIMS were enrolled and followedup for 6-18 months.
Results: 154 patients with an average age of 22±13 yrs underwent
EPS and RFA. Of these 88 Patients had manifest conduction with a
success rate of 90% and 54 concealed conduction with a success
rate of 89%. No patients had procedural complications.6 patients
had atrial fibrillation with rapid antegrade conduction. 4 patients
had multiple pathways which were successfully ablated. 2 pa-
tients had accessory pathway located at CS diverticulum, 1 patient
underwent successful ablation. 2 patients had recurrence of pre-
excitation (left ant. Lat. and left lat. pathway) and underwent
successful reablation.
Conclusions: Our center reports success rates comparable to
other series reports RFA provides long term durable cure from
disabling symptoms and decrease risk of sudden cardiac death
RFA helps to avoid drug related side effects while providing du-
rable cure for tachycardia and minimizing risk of sudden cardiac
death.
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Background: Dual-chamber pacing (DDD) is believed to have an
advantage over single-chamber ventricular pacing (VVI) with a
higher economic burden and peri-operative complication.
The aim of the study was to determine whether patients with
implanted pacemaker (PM) for complete heart block (CHB) gain
significant immediate and long-term benefit from DDD compared
with VVI Pace maker.
Methods: This prospective experimental study included patients
with CHB and DDD Pacing mode for at least 3 months. Patients
were submitted to a standard protocol, which included clinical
assessment, transthoracic echocardiographic examinations,
quality of life (QoL) questionnaires and 6 minute walk test at base
line and during follow-up. Mode change to VVI for 3 months and
shifting back to DDD was done with follow up at 1st day and 3rd
month in both groups. All these parameters obtained were
compared using t test.
Results: Mean patient age was 55.7 ± 14.7 years and PM
implanted for 23.2 ± 25 months. NYHA FC worsened in VVI group.
PM syndrome was presented in 20% in VVI. The mean walking
distance increased in DDD pacing as compared with VVI pacing
(197 + 100.9 m vs 175 ± 100 m, P ¼ 0.005). Within 24 hours there
was marked decrease in pulmonary artery velocity (80 + 30 vs 102
+ 5.2, P¼ <0.001) and marked reduction in Aortic VTI (20.3 + 4.3 vs
23.4 + 4.8, P¼<0.001) in VVI vs DDD and it continued up to 3
months. Transmitral E velocity in VVI pacing mode showed
higher values (89 +26 VS 68 +20, P¼<0.0001). After 3 months there
was increase in EDV in VVI (104 + 28 vs 103.5 + 27.06, P¼0.042) and
decrement in EF (56.97 +10.42 VS 56.6 +10.6, P¼0.02). There is no
significant enlargement of the left atrium in VVI. QoL was
significantly different between the two groups and was better in
DDD group.
Conclusion: DDD pacemaker is better than VVI pacing in terms of
better Functional class, Qol, lesser incidence of pacemaker syn-
drome and Echocardiographic hemodynamic profile.
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